Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19

To develop a model to predict the use of renal replacement therapy (RRT) in COVID-19 patients. Retrospective analysis of multicenter cohort of intensive care unit (ICU) admissions of Brazil involving COVID-19 critically adult patients, requiring ventilatory support, admitted to 126 Brazilian ICUs, f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of critical care 2024-04, Vol.80, p.154480, Article 154480
Hauptverfasser: França, Allan R M, Rocha, Eduardo, Bastos, Leonardo S L, Bozza, Fernando A, Kurtz, Pedro, Maccariello, Elizabeth, Lapa E Silva, José Roberto, Salluh, Jorge I F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 154480
container_title Journal of critical care
container_volume 80
creator França, Allan R M
Rocha, Eduardo
Bastos, Leonardo S L
Bozza, Fernando A
Kurtz, Pedro
Maccariello, Elizabeth
Lapa E Silva, José Roberto
Salluh, Jorge I F
description To develop a model to predict the use of renal replacement therapy (RRT) in COVID-19 patients. Retrospective analysis of multicenter cohort of intensive care unit (ICU) admissions of Brazil involving COVID-19 critically adult patients, requiring ventilatory support, admitted to 126 Brazilian ICUs, from February 2020 to December 2021 (development) and January to May 2022 (validation). No interventions were performed. Eight machine learning models' classifications were evaluated. Models were developed using an 80/20 testing/train split ratio and cross-validation. Thirteen candidate predictors were selected using the Recursive Feature Elimination (RFE) algorithm. Discrimination and calibration were assessed. Temporal validation was performed using data from 2022. Of 14,374 COVID-19 patients with initial respiratory support, 1924 (13%) required RRT. RRT patients were older (65 [53-75] vs. 55 [42-68]), had more comorbidities (Charlson's Comorbidity Index 1.0 [0.00-2.00] vs 0.0 [0.00-1.00]), had higher severity (SAPS-3 median: 61 [51-74] vs 48 [41-58]), and had higher in-hospital mortality (71% vs 22%) compared to non-RRT. Risk factors for RRT, such as Creatinine, Glasgow Coma Scale, Urea, Invasive Mechanical Ventilation, Age, Chronic Kidney Disease, Platelets count, Vasopressors, Noninvasive Ventilation, Hypertension, Diabetes, modified frailty index (mFI) and Gender, were identified. The best discrimination and calibration were found in the Random Forest (AUC [95%CI]: 0.78 [0.75-0.81] and Brier's Score: 0.09 [95%CI: 0.08-0.10]). The final model (Random Forest) showed comparable performance in the temporal validation (AUC [95%CI]: 0.79 [0.75-0.84] and Brier's Score, 0.08 [95%CI: 0.08-0.1]). An early ML model using easily available clinical and laboratory data accurately predicted the use of RRT in critically ill patients with COVID-19. Our study demonstrates that using ML techniques is feasible to provide early prediction of use of RRT in COVID-19 patients.
doi_str_mv 10.1016/j.jcrc.2023.154480
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2895260746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2916416137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-b8822a7de893a31effcaa99ec58ab876f3c2af3e756d39ea4efce212b972528e3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EokvhD3BAlrhwIFt_JLF9RFs-KlXqpXC1Zp0Jm8ixg50U9Rf0b-NlC4deZg7zvK80egh5y9mWM95ejNvRJbcVTMgtb-pas2dkw5tGVbrlzXOyYVrLytQ1PyOvch4Z40rK5iU5k7rkhWg35OES79DHecKwUAgdvQM_dLAMMdDYU6ATuMMQkHqEFIbwk06xQ0-XSOeE3eAWuhyQrhmPeMIAvszZg8O_leWYYL6nQ6C8_ihVTedSXi6Z_h6WA93d_Li6rLh5TV704DO-edzn5PuXz7e7b9X1zder3afryknJl2qvtRCgOtRGguTY9w7AGHSNhr1WbS-dgF6iatpOGoQae4eCi71RohEa5Tn5cOqdU_y1Yl7sNGSH3kPAuGYrtGlEy1TdFvT9E3SMayoPFsrwtuYtl6pQ4kS5FHNO2Ns5DROke8uZPWqyoz1qskdN9qSphN49Vq_7Cbv_kX9e5B-Mso71</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2916416137</pqid></control><display><type>article</type><title>Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>França, Allan R M ; Rocha, Eduardo ; Bastos, Leonardo S L ; Bozza, Fernando A ; Kurtz, Pedro ; Maccariello, Elizabeth ; Lapa E Silva, José Roberto ; Salluh, Jorge I F</creator><creatorcontrib>França, Allan R M ; Rocha, Eduardo ; Bastos, Leonardo S L ; Bozza, Fernando A ; Kurtz, Pedro ; Maccariello, Elizabeth ; Lapa E Silva, José Roberto ; Salluh, Jorge I F</creatorcontrib><description>To develop a model to predict the use of renal replacement therapy (RRT) in COVID-19 patients. Retrospective analysis of multicenter cohort of intensive care unit (ICU) admissions of Brazil involving COVID-19 critically adult patients, requiring ventilatory support, admitted to 126 Brazilian ICUs, from February 2020 to December 2021 (development) and January to May 2022 (validation). No interventions were performed. Eight machine learning models' classifications were evaluated. Models were developed using an 80/20 testing/train split ratio and cross-validation. Thirteen candidate predictors were selected using the Recursive Feature Elimination (RFE) algorithm. Discrimination and calibration were assessed. Temporal validation was performed using data from 2022. Of 14,374 COVID-19 patients with initial respiratory support, 1924 (13%) required RRT. RRT patients were older (65 [53-75] vs. 55 [42-68]), had more comorbidities (Charlson's Comorbidity Index 1.0 [0.00-2.00] vs 0.0 [0.00-1.00]), had higher severity (SAPS-3 median: 61 [51-74] vs 48 [41-58]), and had higher in-hospital mortality (71% vs 22%) compared to non-RRT. Risk factors for RRT, such as Creatinine, Glasgow Coma Scale, Urea, Invasive Mechanical Ventilation, Age, Chronic Kidney Disease, Platelets count, Vasopressors, Noninvasive Ventilation, Hypertension, Diabetes, modified frailty index (mFI) and Gender, were identified. The best discrimination and calibration were found in the Random Forest (AUC [95%CI]: 0.78 [0.75-0.81] and Brier's Score: 0.09 [95%CI: 0.08-0.10]). The final model (Random Forest) showed comparable performance in the temporal validation (AUC [95%CI]: 0.79 [0.75-0.84] and Brier's Score, 0.08 [95%CI: 0.08-0.1]). An early ML model using easily available clinical and laboratory data accurately predicted the use of RRT in critically ill patients with COVID-19. Our study demonstrates that using ML techniques is feasible to provide early prediction of use of RRT in COVID-19 patients.</description><identifier>ISSN: 0883-9441</identifier><identifier>ISSN: 1557-8615</identifier><identifier>EISSN: 1557-8615</identifier><identifier>DOI: 10.1016/j.jcrc.2023.154480</identifier><identifier>PMID: 38016226</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Acute Kidney Injury - therapy ; Adult ; Calibration ; Catheters ; Coronaviruses ; COVID-19 ; COVID-19 - therapy ; Critical Illness ; Feature selection ; Humans ; Intensive Care Units ; Lungs ; Machine Learning ; Mortality ; Ostomy ; Patient admissions ; Probability ; Regression analysis ; Renal replacement therapy ; Renal Replacement Therapy - methods ; Retrospective Studies ; Tracheotomy ; Variables ; Ventilators</subject><ispartof>Journal of critical care, 2024-04, Vol.80, p.154480, Article 154480</ispartof><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><rights>2023. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-b8822a7de893a31effcaa99ec58ab876f3c2af3e756d39ea4efce212b972528e3</citedby><cites>FETCH-LOGICAL-c331t-b8822a7de893a31effcaa99ec58ab876f3c2af3e756d39ea4efce212b972528e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38016226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>França, Allan R M</creatorcontrib><creatorcontrib>Rocha, Eduardo</creatorcontrib><creatorcontrib>Bastos, Leonardo S L</creatorcontrib><creatorcontrib>Bozza, Fernando A</creatorcontrib><creatorcontrib>Kurtz, Pedro</creatorcontrib><creatorcontrib>Maccariello, Elizabeth</creatorcontrib><creatorcontrib>Lapa E Silva, José Roberto</creatorcontrib><creatorcontrib>Salluh, Jorge I F</creatorcontrib><title>Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19</title><title>Journal of critical care</title><addtitle>J Crit Care</addtitle><description>To develop a model to predict the use of renal replacement therapy (RRT) in COVID-19 patients. Retrospective analysis of multicenter cohort of intensive care unit (ICU) admissions of Brazil involving COVID-19 critically adult patients, requiring ventilatory support, admitted to 126 Brazilian ICUs, from February 2020 to December 2021 (development) and January to May 2022 (validation). No interventions were performed. Eight machine learning models' classifications were evaluated. Models were developed using an 80/20 testing/train split ratio and cross-validation. Thirteen candidate predictors were selected using the Recursive Feature Elimination (RFE) algorithm. Discrimination and calibration were assessed. Temporal validation was performed using data from 2022. Of 14,374 COVID-19 patients with initial respiratory support, 1924 (13%) required RRT. RRT patients were older (65 [53-75] vs. 55 [42-68]), had more comorbidities (Charlson's Comorbidity Index 1.0 [0.00-2.00] vs 0.0 [0.00-1.00]), had higher severity (SAPS-3 median: 61 [51-74] vs 48 [41-58]), and had higher in-hospital mortality (71% vs 22%) compared to non-RRT. Risk factors for RRT, such as Creatinine, Glasgow Coma Scale, Urea, Invasive Mechanical Ventilation, Age, Chronic Kidney Disease, Platelets count, Vasopressors, Noninvasive Ventilation, Hypertension, Diabetes, modified frailty index (mFI) and Gender, were identified. The best discrimination and calibration were found in the Random Forest (AUC [95%CI]: 0.78 [0.75-0.81] and Brier's Score: 0.09 [95%CI: 0.08-0.10]). The final model (Random Forest) showed comparable performance in the temporal validation (AUC [95%CI]: 0.79 [0.75-0.84] and Brier's Score, 0.08 [95%CI: 0.08-0.1]). An early ML model using easily available clinical and laboratory data accurately predicted the use of RRT in critically ill patients with COVID-19. Our study demonstrates that using ML techniques is feasible to provide early prediction of use of RRT in COVID-19 patients.</description><subject>Acute Kidney Injury - therapy</subject><subject>Adult</subject><subject>Calibration</subject><subject>Catheters</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - therapy</subject><subject>Critical Illness</subject><subject>Feature selection</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>Lungs</subject><subject>Machine Learning</subject><subject>Mortality</subject><subject>Ostomy</subject><subject>Patient admissions</subject><subject>Probability</subject><subject>Regression analysis</subject><subject>Renal replacement therapy</subject><subject>Renal Replacement Therapy - methods</subject><subject>Retrospective Studies</subject><subject>Tracheotomy</subject><subject>Variables</subject><subject>Ventilators</subject><issn>0883-9441</issn><issn>1557-8615</issn><issn>1557-8615</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1v1DAQhi0EokvhD3BAlrhwIFt_JLF9RFs-KlXqpXC1Zp0Jm8ixg50U9Rf0b-NlC4deZg7zvK80egh5y9mWM95ejNvRJbcVTMgtb-pas2dkw5tGVbrlzXOyYVrLytQ1PyOvch4Z40rK5iU5k7rkhWg35OES79DHecKwUAgdvQM_dLAMMdDYU6ATuMMQkHqEFIbwk06xQ0-XSOeE3eAWuhyQrhmPeMIAvszZg8O_leWYYL6nQ6C8_ihVTedSXi6Z_h6WA93d_Li6rLh5TV704DO-edzn5PuXz7e7b9X1zder3afryknJl2qvtRCgOtRGguTY9w7AGHSNhr1WbS-dgF6iatpOGoQae4eCi71RohEa5Tn5cOqdU_y1Yl7sNGSH3kPAuGYrtGlEy1TdFvT9E3SMayoPFsrwtuYtl6pQ4kS5FHNO2Ns5DROke8uZPWqyoz1qskdN9qSphN49Vq_7Cbv_kX9e5B-Mso71</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>França, Allan R M</creator><creator>Rocha, Eduardo</creator><creator>Bastos, Leonardo S L</creator><creator>Bozza, Fernando A</creator><creator>Kurtz, Pedro</creator><creator>Maccariello, Elizabeth</creator><creator>Lapa E Silva, José Roberto</creator><creator>Salluh, Jorge I F</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19</title><author>França, Allan R M ; Rocha, Eduardo ; Bastos, Leonardo S L ; Bozza, Fernando A ; Kurtz, Pedro ; Maccariello, Elizabeth ; Lapa E Silva, José Roberto ; Salluh, Jorge I F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-b8822a7de893a31effcaa99ec58ab876f3c2af3e756d39ea4efce212b972528e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute Kidney Injury - therapy</topic><topic>Adult</topic><topic>Calibration</topic><topic>Catheters</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - therapy</topic><topic>Critical Illness</topic><topic>Feature selection</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>Lungs</topic><topic>Machine Learning</topic><topic>Mortality</topic><topic>Ostomy</topic><topic>Patient admissions</topic><topic>Probability</topic><topic>Regression analysis</topic><topic>Renal replacement therapy</topic><topic>Renal Replacement Therapy - methods</topic><topic>Retrospective Studies</topic><topic>Tracheotomy</topic><topic>Variables</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>França, Allan R M</creatorcontrib><creatorcontrib>Rocha, Eduardo</creatorcontrib><creatorcontrib>Bastos, Leonardo S L</creatorcontrib><creatorcontrib>Bozza, Fernando A</creatorcontrib><creatorcontrib>Kurtz, Pedro</creatorcontrib><creatorcontrib>Maccariello, Elizabeth</creatorcontrib><creatorcontrib>Lapa E Silva, José Roberto</creatorcontrib><creatorcontrib>Salluh, Jorge I F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of critical care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>França, Allan R M</au><au>Rocha, Eduardo</au><au>Bastos, Leonardo S L</au><au>Bozza, Fernando A</au><au>Kurtz, Pedro</au><au>Maccariello, Elizabeth</au><au>Lapa E Silva, José Roberto</au><au>Salluh, Jorge I F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19</atitle><jtitle>Journal of critical care</jtitle><addtitle>J Crit Care</addtitle><date>2024-04</date><risdate>2024</risdate><volume>80</volume><spage>154480</spage><pages>154480-</pages><artnum>154480</artnum><issn>0883-9441</issn><issn>1557-8615</issn><eissn>1557-8615</eissn><abstract>To develop a model to predict the use of renal replacement therapy (RRT) in COVID-19 patients. Retrospective analysis of multicenter cohort of intensive care unit (ICU) admissions of Brazil involving COVID-19 critically adult patients, requiring ventilatory support, admitted to 126 Brazilian ICUs, from February 2020 to December 2021 (development) and January to May 2022 (validation). No interventions were performed. Eight machine learning models' classifications were evaluated. Models were developed using an 80/20 testing/train split ratio and cross-validation. Thirteen candidate predictors were selected using the Recursive Feature Elimination (RFE) algorithm. Discrimination and calibration were assessed. Temporal validation was performed using data from 2022. Of 14,374 COVID-19 patients with initial respiratory support, 1924 (13%) required RRT. RRT patients were older (65 [53-75] vs. 55 [42-68]), had more comorbidities (Charlson's Comorbidity Index 1.0 [0.00-2.00] vs 0.0 [0.00-1.00]), had higher severity (SAPS-3 median: 61 [51-74] vs 48 [41-58]), and had higher in-hospital mortality (71% vs 22%) compared to non-RRT. Risk factors for RRT, such as Creatinine, Glasgow Coma Scale, Urea, Invasive Mechanical Ventilation, Age, Chronic Kidney Disease, Platelets count, Vasopressors, Noninvasive Ventilation, Hypertension, Diabetes, modified frailty index (mFI) and Gender, were identified. The best discrimination and calibration were found in the Random Forest (AUC [95%CI]: 0.78 [0.75-0.81] and Brier's Score: 0.09 [95%CI: 0.08-0.10]). The final model (Random Forest) showed comparable performance in the temporal validation (AUC [95%CI]: 0.79 [0.75-0.84] and Brier's Score, 0.08 [95%CI: 0.08-0.1]). An early ML model using easily available clinical and laboratory data accurately predicted the use of RRT in critically ill patients with COVID-19. Our study demonstrates that using ML techniques is feasible to provide early prediction of use of RRT in COVID-19 patients.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>38016226</pmid><doi>10.1016/j.jcrc.2023.154480</doi></addata></record>
fulltext fulltext
identifier ISSN: 0883-9441
ispartof Journal of critical care, 2024-04, Vol.80, p.154480, Article 154480
issn 0883-9441
1557-8615
1557-8615
language eng
recordid cdi_proquest_miscellaneous_2895260746
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute Kidney Injury - therapy
Adult
Calibration
Catheters
Coronaviruses
COVID-19
COVID-19 - therapy
Critical Illness
Feature selection
Humans
Intensive Care Units
Lungs
Machine Learning
Mortality
Ostomy
Patient admissions
Probability
Regression analysis
Renal replacement therapy
Renal Replacement Therapy - methods
Retrospective Studies
Tracheotomy
Variables
Ventilators
title Development and validation of a machine learning model to predict the use of renal replacement therapy in 14,374 patients with COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20machine%20learning%20model%20to%20predict%20the%20use%20of%20renal%20replacement%20therapy%20in%2014,374%20patients%20with%20COVID-19&rft.jtitle=Journal%20of%20critical%20care&rft.au=Fran%C3%A7a,%20Allan%20R%20M&rft.date=2024-04&rft.volume=80&rft.spage=154480&rft.pages=154480-&rft.artnum=154480&rft.issn=0883-9441&rft.eissn=1557-8615&rft_id=info:doi/10.1016/j.jcrc.2023.154480&rft_dat=%3Cproquest_cross%3E2916416137%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2916416137&rft_id=info:pmid/38016226&rfr_iscdi=true